121 related articles for article (PubMed ID: 29226893)
1. Assessment of factors related to statin non-adherence in patients with established coronary artery disease: A single-center observational study.
Özdemir T; Şahin İ; Avcı İİ; Güngör B; Durmaz E; Tuğrul S; Hayıroğlu Mİ; Kahyaoğlu S; Karımov O; Okuyan E
Turk Kardiyol Dern Ars; 2017 Dec; 45(8):723-730. PubMed ID: 29226893
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study).
Tokgözoğlu L; Özdemir R; Altındağ R; Ceyhan C; Yeter E; Öztürk C; Bayram F; Delibaşı T; Değertekin M; Dinçkal MH; Keleş İ; Fak AS; Aydoğdu S; Zorkun C; Tartan Z
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):53-64. PubMed ID: 26875131
[TBL] [Abstract][Full Text] [Related]
3. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
Kazerooni R; Watanabe JH; Bounthavong M
Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
[TBL] [Abstract][Full Text] [Related]
4. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
5. Statin therapy is associated with lower all-cause mortality in patients with non-obstructive coronary artery disease.
Hwang IC; Jeon JY; Kim Y; Kim HM; Yoon YE; Lee SP; Kim HK; Sohn DW; Sung J; Kim YJ
Atherosclerosis; 2015 Apr; 239(2):335-42. PubMed ID: 25682032
[TBL] [Abstract][Full Text] [Related]
6. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
7. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
9. Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients.
Lama S; Souraya D; Youssef F
Int J Clin Pharm; 2017 Aug; 39(4):919-926. PubMed ID: 28523462
[TBL] [Abstract][Full Text] [Related]
10. Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease.
O'Brien EC; Wu J; Schulte PJ; Christian A; Laskey W; Bhatt DL; Peterson ED; Hernandez AF; Fonarow GC
Am Heart J; 2016 Mar; 173():27-34. PubMed ID: 26920593
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol.
Hulten E; Bittencourt MS; Singh A; O'Leary D; Christman MP; Osmani W; Abbara S; Steigner ML; Truong QA; Nasir K; Rybicki FF; Klein J; Hainer J; Brady TJ; Hoffmann U; Ghoshhajra BB; Hachamovitch R; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2014 Jul; 7(4):629-38. PubMed ID: 24906356
[TBL] [Abstract][Full Text] [Related]
12. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
13. Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol.
Lee SY; Oh SJ; Kim EJ; Oum CY; Park SH; Oh J; Kim JS; Kim BK; Park S; Chang HJ; Hong GR; Ko YG; Kang SM; Choi D; Ha JW; Hong MK; Jang Y; Chung N; Lee SH
PLoS One; 2016; 11(11):e0166246. PubMed ID: 27824924
[TBL] [Abstract][Full Text] [Related]
14. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
[TBL] [Abstract][Full Text] [Related]
16. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
Ivers NM; Schwalm JD; Jackevicius CA; Guo H; Tu JV; Natarajan M
Can J Cardiol; 2013 Nov; 29(11):1408-14. PubMed ID: 23816280
[TBL] [Abstract][Full Text] [Related]
17. Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.
Muntner P; Yun H; Sharma P; Delzell E; Kent ST; Kilgore ML; Farkouh ME; Vupputuri S; Bittner V; Rosenson RS; Levitan EB; Safford MM
Am J Cardiol; 2014 Sep; 114(6):826-31. PubMed ID: 25103917
[TBL] [Abstract][Full Text] [Related]
18. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
19. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
[TBL] [Abstract][Full Text] [Related]
20. Changes in preventive medical therapies and CV risk factors after CT angiography.
Cheezum MK; Hulten EA; Smith RM; Taylor AJ; Kircher J; Surry L; York M; Villines TC
JACC Cardiovasc Imaging; 2013 May; 6(5):574-81. PubMed ID: 23582355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
